A biopharmaceutical company, pioneering a unique, highly integrated chemical genetics platform for drug discovery and development - focused on oncology & autoimmune/inflammatory diseases More
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) designs, optimizes and develops novel drugs that block key enzymes essential for viral, cardiovascular and oncologic disease processes. More
CytoGenix, Inc. is a biopharmaceutical company that develops and markets innovative compounds and services based on its proprietary gene regulating technology. More